Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival

World Journal of Surgery

Volumn 38, Issue 8, 2014, Pages 2160-2167

  Maier, Herbert Thomas ^a   Aigner, Felix ^a   Trenkwalder, Birgit ^a   Zitt, Matthias ^a   Vallant, Natalie ^a   Perathoner, Alexander ^a   Margreiter, Christian ^a   Moser, Patrizia ^b   Pratschke, Johann ^a   Amberger, Albert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

AGED; CANCER STAGING; CARCINOMA; CHEMISTRY; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HT 29 CELL LINE; HUMAN; INTESTINE MUCOSA; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY; SURVIVAL RATE; UPREGULATION;

ACUTE-PHASE PROTEINS; AGED; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; KAPLAN-MEIER ESTIMATE; LIPOCALINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE; UP-REGULATION;

EID: 84903776150     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2499-x     Document Type: Article

References (38)

1. Wilkinson N, Scott-Conner CE (2008) Surgical therapy for colorectal adenocarcinoma. Gastroenterol Clin N Am 37:253-267 (Pubitemid 351289030)
2. Carethers JM (2012) Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer. J Gastrointestinal Surg 16:1648-1650
3. Hegde SR, Sun W, Lynch JP (2008) Systemic and targeted therapy for advanced colon cancer. Expert Rev Gastroenterol Hepatol 2:135-149
4. McLean MH, Thomson AJ, Murray GI et al (2013) Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential? Br J Cancer 108:2537-2541
5. Marti J, Fuster J, Sola AM et al (2013) Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer. World J Surg 37:1103-1109. doi: 10.1007/s00268-013-1930-z
6. Hraba-Renevey S, Turler H, Kress M et al (1989) SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4:601-608 (Pubitemid 19139712)
7. Nielsen BS, Borregaard N, Bundgaard JR et al (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38:414-420
8. Friedl A, Stoesz SP, Buckley P et al (1999) Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues: cell type-specific pattern of expression. Histochem J 31:433-441 (Pubitemid 29369301)
9. Lee HJ, Lee EK, Lee KJ et al (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer 118:2490-2497
10. Stoesz SP, Friedl A, Haag JD et al (1998) Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79:565-572 (Pubitemid 28549466)
11. Furutani M, Arii S, Mizumoto M et al (1998) Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 122:209-214 (Pubitemid 28058638)
12. Lim R, Ahmed N, Borregaard N et al (2007) Neutrophil gelatinase- associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 120:2426-2434 (Pubitemid 46642130)
13. Li EM, Xu LY, Cai WJ et al (2003) Functions of neutrophil gelatinase-associated lipocalin in the esophageal carcinoma cell line SHEEC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35:247-254
14. Tong Z, Wu X, Ovcharenko D et al (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 391(Pt 2):441-448 (Pubitemid 41532443)
15. Yang J, Bielenberg DR, Rodig SJ et al (2009) Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA 106:3913-3918
16. Yan L, Borregaard N, Kjeldsen L et al (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL): modulation of MMP-9 activity by NGAL. J Biol Chem 276:37258-37265
17. Fernandez CA, Yan L, Louis G et al (2005) The matrix metalloproteinase-9/ neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11:5390-5395 (Pubitemid 41060812)
18. Van de Velde CJ, Aristei C, Boelens PG et al (2013) EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 49:2784-2790
19. Perathoner A, Pirkebner D, Brandacher G et al (2005) 14-3-3σ Expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res 11:3274-3279 (Pubitemid 40627875)
20. Gastl G, Spizzo G, Obrist P et al (2000) Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356:1981-1982
21. Zlobec I, Terracciano L, Jass JR et al (2007) Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch 451:763-769 (Pubitemid 47497938)
22. Ancona N, Maglietta R, Piepoli A et al (2006) On the statistical assessment of classifiers using DNA microarray data. BMC Bioinf 7:387 (Pubitemid 44390022)
23. Chowdary D, Lathrop J, Skelton J et al (2006) Prognostic gene expression signatures can be measured in tissues collected in RNA later preservative. J Mol Diagn 8:31-39 (Pubitemid 43257432)
24. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337
25. Bauer M, Eickhoff JC, Gould MN et al (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 108:389-397 (Pubitemid 351431077)
26. Sier CF, Kubben FJ, Ganesh S et al (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74:413-417 (Pubitemid 26254571)
27. Anderson LN, Cotterchio M, Knight JA et al (2013) Genetic variants in vitamin D pathway genes and risk of pancreas cancer; results from a population-based case-control study in Ontario, Canada. PLoS ONE 24:8
28. Tong Z, Kunnumakkara AB, Wang H et al (2008) Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 68:6100-6108
29. Chakraborty S, Kaur S, Guha S et al (2012) The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 1826:129-169
30. Volpe V, Raia Z, Sanguigno L et al (2013) NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells. J Clin Endocrinol Metab 98:228-235
31. Hu L, Hittelman W, Lu T et al (2009) NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Investig 89:531-548
32. Zhang H, Xu L, Xiao D et al (2007) Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 60:555-561 (Pubitemid 46867169)
33. Gwira JA, Wei F, Ishibe S et al (2005) Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 280:7875-7882 (Pubitemid 40349684)
34. Wenners AS, Mehta K, Loibl S et al (2012) Neutrophil gelatinase- associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer. PLoS ONE 7:e45826
35. Gervaz P, Bucher P, Morel P (2004) Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 88:261-266 (Pubitemid 39601269)
36. Azzoni C, Bottarelli L, Campanini N et al (2007) Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis 22:115-126 (Pubitemid 44964014)
37. Ishihara S, Watanabe T, Akahane T et al (2012) Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis 27:371-379
38. Bao G, Clifton M, Hoette TM et al (2010) Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol 6:602-609